KUALA LUMPUR (May 24): Mah Sing Healthcare Sdn Bhd has received its business licence and other relevant licences and permits, with operations starting at its Kapar facility in Klang, it said in a statement today.

The company has received an export licence from the Malaysian Rubber Board, as well as two Food and Drug Administration (FDA) Establishment Licences for Polymer Nitrile Patient Examination Glove and Latex Patient Examination Glove from the US FDA, which enable Mah Sing Healthcare to export its gloves to the US.

“It is also progressing well in obtaining FDA 510(k) Premarket Notification and the Conformitè Europëenne (CE) Marking for exports to the US and European markets respectively.

“This new milestone places Mah Sing among the first few new glove entrants in Malaysia to commence glove production to meet immediate market demand,” it said.

Mah Sing Healthcare, a division of Mah Sing Group Bhd primarily involved in real estate development, said it expects to deiver its first shipment of gloves by this month or next month.

“The group has secured sufficient raw materials to meet orders and interests from its buyers and distributors, which are mainly serving markets such as the US, Canada, the Middle East, Europe, the UK, Japan, China, South Korea, Singapore, Russia and Latin America,” it said.

According to the company, six production lines are on track to being operational in the second quarter of 2021 (2Q21), followed by another six production lines in the following quarter.

“The maximum production capacity of the 12 lines is up to 3.68 billion pieces of gloves per annum. These 12 units of new, high-speed glove dipping machines — producing at a speed of 38,000 pieces of gloves per production line per hour — are under Phase 1 of Mah Sing’s glove manufacturing business.

“If demand continues to outstrip supply, Mah Sing would expand Phase 2 — which consists of another 12 glove production lines. Phase 2 would increase the capacity up to another 3.68 billion pieces of gloves per annum, doubling the initial production capacity,” it said.

As at 11.34am today, Mah Sing Group’s share price was 2.5 sen or 2.75% higher at 93.5 sen, giving it a market capitalisation of RM2.2 billion.